Industri

Tenthpin launches Bengaluru Innovation Hub for life sci...

Centre will focus on AI, cloud technologies, advanced therapies, IoMT and intel...

Merck expands Jigani facility to boost life science man...

€13 million investment will add biological buffer manufacturing and expand chem...

Gujarat Themis Biosyn completes JPY 21.5 billion acquis...

The acquisition gives GTBL access to MBJ’s fermentation, biotechnology and CDMO...

Dr Sundaram Palaniswamy, Senior Global Product Manager ...

Bengaluru Pharma Summit 2026 | 25th August 2026 The post Dr Sundaram Palaniswam...

Dr Parthasarathy Sampathkumar, Head Group – COE, Biocon

Bengaluru Pharma Summit 2026 | 25th August 2026 The post Dr Parthasarathy Sampa...

Mr Prashanth Bajaj, Business Unit Director, Lindstrom S...

Bengaluru Pharma Summit 2026 | 25th August 2026 The post Mr Prashanth Bajaj, Bu...

Mr Vasudevan (Vasu) Ramanujam, Global Business Head, In...

Bengaluru Pharma Summit 2026 | 25th August 2026 The post Mr Vasudevan (Vasu) Ra...

Dr Pravin Mhapankar, Director, Thermolab Scientific Equ...

Bengaluru Pharma Summit 2026 | 25th August 2026 The post Dr Pravin Mhapankar, D...

Panel Discussion: The new innovation economy: Building ...

Bengaluru Pharma Summit 2026 | 25th August 2026 The post Panel Discussion: The ...

Mr Loganathan S, AVP, Onesource Biopharma

Bengaluru Pharma Summit 2026 | 25th August 2026 The post Mr Loganathan S, AVP, ...

Panel Discussion: The biopharma pivot: Can India move f...

Bengaluru Pharma Summit 2026 | 25th August 2026 The post Panel Discussion: The ...

Panel Discussion: The Bengaluru Bet: How GCCs are redef...

Bengaluru Pharma Summit 2026 | 25th August 2026 The post Panel Discussion: The ...

Geopolitics and pharma packaging: Building greater secu...

India’s pharma strength and its new operating reality  The Indian pharmaceutica...

GST on vaccines: Time for clarity, not litigation

Santosh Dalvi and Saurabh Jain highlight the need for clarity on GST classifica...

Cellares and GenomeFrontier to assess automated GF-CART...

The collaboration, which marks Cellares’ first development project in Asia, will...

Viatris’ Wakix receives Japanese approval to treat OSAS...

The approval covers patients with OSAS who continue to experience EDS while rece...